Back
Plus Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
PSTV
Plus Therapeutics
Last Price:
$0.75
Seasonality Move:
-9.9%
7 Day Trial
ALL ACCESS PASS
$
7

[Urgent Alert] This unique trade could land you 100% gains in 10 days
Discover how much you can make with this "Friday Phenomenon."-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight buying pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.81 | Sell |
20-day SMA: | 0.97 | Sell |
50-day SMA: | 1.03 | Sell |
200-day SMA: | 1.31 | Sell |
8-day EMA: | 0.84 | Sell |
20-day EMA: | 0.93 | Sell |
50-day EMA: | 1.02 | Sell |
200-day EMA: | 1.34 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 43.58 | Sell |
Chaikin Money Flow: | -17015 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.68 - 1.32) | Sell |
Bollinger Bands (100): | (0.88 - 1.36) | Sell |
Plus Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.75 while PSTV 8-day simple moving average is 0.81, which is a Sell signal.
-
The stock price of PSTV is 0.75 while Plus Therapeutics 20-day SMA is 0.97, which makes it a Sell.
-
Plus Therapeutics 50-day simple moving average is 1.03 while PSTV share price is 0.75, making it a Sell technically.
-
PSTV stock price is 0.75 and Plus Therapeutics 200-day simple moving average is 1.31, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
17
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a SellThe current Plus Therapeutics [PSTV] share price is $0.75. The Score for PSTV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
12.7M
Price in USD:
0.75
Share Volume:
436.9K
Plus Therapeutics 52-Week Range
52-Week High:
2.67
52-Week Low:
0.24
Sell
17
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?The Plus Therapeutics stock price is 0.75 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.75 while PSTV 8-day exponential moving average is 0.84, which is a Sell signal.
-
The stock price of PSTV is 0.75 while Plus Therapeutics 20-day EMA is 0.93, which makes it a Sell.
-
Plus Therapeutics 50-day exponential moving average is 1.02 while PSTV share price is 0.75, making it a Sell technically.
-
PSTV stock price is 0.75 and Plus Therapeutics 200-day simple moving average is 1.34, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $0.11 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Plus Therapeutics is a Sell
-
Plus Therapeutics Relative Strength Index (RSI) is 43.58, which suggest Plus Therapeutics is oversold
-
The Bollinger Bands (25) for Plus Therapeutics is (0.68 - 1.32), which suggest Plus Therapeutics is a Sell
-
The Bollinger Bands (100) for Plus Therapeutics is (0.88 - 1.36), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.